Abstract
Summary
LPI (LP Information)' newest research report, the “Vaccine Syringes Industry Forecast” looks at past sales and reviews total world Vaccine Syringes sales in 2022, providing a comprehensive analysis by region and market sector of projected Vaccine Syringes sales for 2023 through 2029. With Vaccine Syringes sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vaccine Syringes industry.
This Insight Report provides a comprehensive analysis of the global Vaccine Syringes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Syringes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vaccine Syringes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Syringes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Syringes.
The global Vaccine Syringes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccine Syringes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine Syringes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine Syringes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine Syringes players cover BD, Gerresheimer, SCHOTT AG, Nipro Corporation, Stevanato, Baxter Healthcare, Vetter, Catalent and Taisei Kako, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Syringes market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
With Needles
Needleless
Segmentation by application
Hospitals
Clinics
Community Service Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Gerresheimer
SCHOTT AG
Nipro Corporation
Stevanato
Baxter Healthcare
Vetter
Catalent
Taisei Kako
Roselabs Group
West Pharmaceutical Services
Jiangxi Sanxin Medtec
Zhejiang Kangkang Medical Equipment
WEGO
Zibo Minkang
Shandong Ujoin Medical Technology
Jiangxi Hongda Medical Equipment Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vaccine Syringes market?
What factors are driving Vaccine Syringes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Syringes market opportunities vary by end market size?
How does Vaccine Syringes break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Vaccine Syringes landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vaccine Syringes portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vaccine Syringes market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vaccine Syringes and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vaccine Syringes.
The global Vaccine Syringes market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vaccine Syringes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vaccine Syringes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vaccine Syringes is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vaccine Syringes players cover BD, Gerresheimer, SCHOTT AG, Nipro Corporation, Stevanato, Baxter Healthcare, Vetter, Catalent and Taisei Kako, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Syringes market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
With Needles
Needleless
Segmentation by application
Hospitals
Clinics
Community Service Center
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
BD
Gerresheimer
SCHOTT AG
Nipro Corporation
Stevanato
Baxter Healthcare
Vetter
Catalent
Taisei Kako
Roselabs Group
West Pharmaceutical Services
Jiangxi Sanxin Medtec
Zhejiang Kangkang Medical Equipment
WEGO
Zibo Minkang
Shandong Ujoin Medical Technology
Jiangxi Hongda Medical Equipment Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vaccine Syringes market?
What factors are driving Vaccine Syringes market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vaccine Syringes market opportunities vary by end market size?
How does Vaccine Syringes break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Syringes Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vaccine Syringes by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vaccine Syringes by Country/Region, 2018, 2022 & 2029
2.2 Vaccine Syringes Segment by Type
2.2.1 With Needles
2.2.2 Needleless
2.3 Vaccine Syringes Sales by Type
2.3.1 Global Vaccine Syringes Sales Market Share by Type (2018-2023)
2.3.2 Global Vaccine Syringes Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vaccine Syringes Sale Price by Type (2018-2023)
2.4 Vaccine Syringes Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Community Service Center
2.5 Vaccine Syringes Sales by Application
2.5.1 Global Vaccine Syringes Sale Market Share by Application (2018-2023)
2.5.2 Global Vaccine Syringes Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vaccine Syringes Sale Price by Application (2018-2023)
3 Global Vaccine Syringes by Company
3.1 Global Vaccine Syringes Breakdown Data by Company
3.1.1 Global Vaccine Syringes Annual Sales by Company (2018-2023)
3.1.2 Global Vaccine Syringes Sales Market Share by Company (2018-2023)
3.2 Global Vaccine Syringes Annual Revenue by Company (2018-2023)
3.2.1 Global Vaccine Syringes Revenue by Company (2018-2023)
3.2.2 Global Vaccine Syringes Revenue Market Share by Company (2018-2023)
3.3 Global Vaccine Syringes Sale Price by Company
3.4 Key Manufacturers Vaccine Syringes Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vaccine Syringes Product Location Distribution
3.4.2 Players Vaccine Syringes Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vaccine Syringes by Geographic Region
4.1 World Historic Vaccine Syringes Market Size by Geographic Region (2018-2023)
4.1.1 Global Vaccine Syringes Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vaccine Syringes Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vaccine Syringes Market Size by Country/Region (2018-2023)
4.2.1 Global Vaccine Syringes Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vaccine Syringes Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vaccine Syringes Sales Growth
4.4 APAC Vaccine Syringes Sales Growth
4.5 Europe Vaccine Syringes Sales Growth
4.6 Middle East & Africa Vaccine Syringes Sales Growth
5 Americas
5.1 Americas Vaccine Syringes Sales by Country
5.1.1 Americas Vaccine Syringes Sales by Country (2018-2023)
5.1.2 Americas Vaccine Syringes Revenue by Country (2018-2023)
5.2 Americas Vaccine Syringes Sales by Type
5.3 Americas Vaccine Syringes Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vaccine Syringes Sales by Region
6.1.1 APAC Vaccine Syringes Sales by Region (2018-2023)
6.1.2 APAC Vaccine Syringes Revenue by Region (2018-2023)
6.2 APAC Vaccine Syringes Sales by Type
6.3 APAC Vaccine Syringes Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vaccine Syringes by Country
7.1.1 Europe Vaccine Syringes Sales by Country (2018-2023)
7.1.2 Europe Vaccine Syringes Revenue by Country (2018-2023)
7.2 Europe Vaccine Syringes Sales by Type
7.3 Europe Vaccine Syringes Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vaccine Syringes by Country
8.1.1 Middle East & Africa Vaccine Syringes Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vaccine Syringes Revenue by Country (2018-2023)
8.2 Middle East & Africa Vaccine Syringes Sales by Type
8.3 Middle East & Africa Vaccine Syringes Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vaccine Syringes
10.3 Manufacturing Process Analysis of Vaccine Syringes
10.4 Industry Chain Structure of Vaccine Syringes
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vaccine Syringes Distributors
11.3 Vaccine Syringes Customer
12 World Forecast Review for Vaccine Syringes by Geographic Region
12.1 Global Vaccine Syringes Market Size Forecast by Region
12.1.1 Global Vaccine Syringes Forecast by Region (2024-2029)
12.1.2 Global Vaccine Syringes Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vaccine Syringes Forecast by Type
12.7 Global Vaccine Syringes Forecast by Application
13 Key Players Analysis
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Vaccine Syringes Product Portfolios and Specifications
13.1.3 BD Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Gerresheimer
13.2.1 Gerresheimer Company Information
13.2.2 Gerresheimer Vaccine Syringes Product Portfolios and Specifications
13.2.3 Gerresheimer Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Gerresheimer Main Business Overview
13.2.5 Gerresheimer Latest Developments
13.3 SCHOTT AG
13.3.1 SCHOTT AG Company Information
13.3.2 SCHOTT AG Vaccine Syringes Product Portfolios and Specifications
13.3.3 SCHOTT AG Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 SCHOTT AG Main Business Overview
13.3.5 SCHOTT AG Latest Developments
13.4 Nipro Corporation
13.4.1 Nipro Corporation Company Information
13.4.2 Nipro Corporation Vaccine Syringes Product Portfolios and Specifications
13.4.3 Nipro Corporation Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nipro Corporation Main Business Overview
13.4.5 Nipro Corporation Latest Developments
13.5 Stevanato
13.5.1 Stevanato Company Information
13.5.2 Stevanato Vaccine Syringes Product Portfolios and Specifications
13.5.3 Stevanato Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Stevanato Main Business Overview
13.5.5 Stevanato Latest Developments
13.6 Baxter Healthcare
13.6.1 Baxter Healthcare Company Information
13.6.2 Baxter Healthcare Vaccine Syringes Product Portfolios and Specifications
13.6.3 Baxter Healthcare Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Baxter Healthcare Main Business Overview
13.6.5 Baxter Healthcare Latest Developments
13.7 Vetter
13.7.1 Vetter Company Information
13.7.2 Vetter Vaccine Syringes Product Portfolios and Specifications
13.7.3 Vetter Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Vetter Main Business Overview
13.7.5 Vetter Latest Developments
13.8 Catalent
13.8.1 Catalent Company Information
13.8.2 Catalent Vaccine Syringes Product Portfolios and Specifications
13.8.3 Catalent Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Catalent Main Business Overview
13.8.5 Catalent Latest Developments
13.9 Taisei Kako
13.9.1 Taisei Kako Company Information
13.9.2 Taisei Kako Vaccine Syringes Product Portfolios and Specifications
13.9.3 Taisei Kako Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Taisei Kako Main Business Overview
13.9.5 Taisei Kako Latest Developments
13.10 Roselabs Group
13.10.1 Roselabs Group Company Information
13.10.2 Roselabs Group Vaccine Syringes Product Portfolios and Specifications
13.10.3 Roselabs Group Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Roselabs Group Main Business Overview
13.10.5 Roselabs Group Latest Developments
13.11 West Pharmaceutical Services
13.11.1 West Pharmaceutical Services Company Information
13.11.2 West Pharmaceutical Services Vaccine Syringes Product Portfolios and Specifications
13.11.3 West Pharmaceutical Services Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 West Pharmaceutical Services Main Business Overview
13.11.5 West Pharmaceutical Services Latest Developments
13.12 Jiangxi Sanxin Medtec
13.12.1 Jiangxi Sanxin Medtec Company Information
13.12.2 Jiangxi Sanxin Medtec Vaccine Syringes Product Portfolios and Specifications
13.12.3 Jiangxi Sanxin Medtec Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jiangxi Sanxin Medtec Main Business Overview
13.12.5 Jiangxi Sanxin Medtec Latest Developments
13.13 Zhejiang Kangkang Medical Equipment
13.13.1 Zhejiang Kangkang Medical Equipment Company Information
13.13.2 Zhejiang Kangkang Medical Equipment Vaccine Syringes Product Portfolios and Specifications
13.13.3 Zhejiang Kangkang Medical Equipment Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Zhejiang Kangkang Medical Equipment Main Business Overview
13.13.5 Zhejiang Kangkang Medical Equipment Latest Developments
13.14 WEGO
13.14.1 WEGO Company Information
13.14.2 WEGO Vaccine Syringes Product Portfolios and Specifications
13.14.3 WEGO Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 WEGO Main Business Overview
13.14.5 WEGO Latest Developments
13.15 Zibo Minkang
13.15.1 Zibo Minkang Company Information
13.15.2 Zibo Minkang Vaccine Syringes Product Portfolios and Specifications
13.15.3 Zibo Minkang Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Zibo Minkang Main Business Overview
13.15.5 Zibo Minkang Latest Developments
13.16 Shandong Ujoin Medical Technology
13.16.1 Shandong Ujoin Medical Technology Company Information
13.16.2 Shandong Ujoin Medical Technology Vaccine Syringes Product Portfolios and Specifications
13.16.3 Shandong Ujoin Medical Technology Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Shandong Ujoin Medical Technology Main Business Overview
13.16.5 Shandong Ujoin Medical Technology Latest Developments
13.17 Jiangxi Hongda Medical Equipment Group
13.17.1 Jiangxi Hongda Medical Equipment Group Company Information
13.17.2 Jiangxi Hongda Medical Equipment Group Vaccine Syringes Product Portfolios and Specifications
13.17.3 Jiangxi Hongda Medical Equipment Group Vaccine Syringes Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Jiangxi Hongda Medical Equipment Group Main Business Overview
13.17.5 Jiangxi Hongda Medical Equipment Group Latest Developments
14 Research Findings and Conclusion